BR9607647A - Derivado de insulina e composição farmacêutica e processo para o tratamento de diabetes em um paciente em necessidade deste tratamento - Google Patents
Derivado de insulina e composição farmacêutica e processo para o tratamento de diabetes em um paciente em necessidade deste tratamentoInfo
- Publication number
- BR9607647A BR9607647A BR9607647A BR9607647A BR9607647A BR 9607647 A BR9607647 A BR 9607647A BR 9607647 A BR9607647 A BR 9607647A BR 9607647 A BR9607647 A BR 9607647A BR 9607647 A BR9607647 A BR 9607647A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- diabetes
- patient
- need
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK27695 | 1995-03-17 | ||
PCT/DK1996/000107 WO1996029344A1 (en) | 1995-03-17 | 1996-03-18 | Insulin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9607647A true BR9607647A (pt) | 1999-04-06 |
Family
ID=8091725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9607647A BR9607647A (pt) | 1995-03-17 | 1996-03-18 | Derivado de insulina e composição farmacêutica e processo para o tratamento de diabetes em um paciente em necessidade deste tratamento |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0871665B1 (pt) |
JP (1) | JP3872105B2 (pt) |
KR (1) | KR19980703039A (pt) |
CN (1) | CN1196061A (pt) |
AT (1) | ATE245659T1 (pt) |
AU (1) | AU720966B2 (pt) |
BR (1) | BR9607647A (pt) |
CA (1) | CA2215694A1 (pt) |
CZ (1) | CZ289343B6 (pt) |
DE (1) | DE69629210T2 (pt) |
HU (1) | HUP9800523A3 (pt) |
NO (1) | NO974270L (pt) |
PL (1) | PL183698B1 (pt) |
WO (1) | WO1996029344A1 (pt) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693609A (en) * | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
US6451970B1 (en) | 1996-02-21 | 2002-09-17 | Novo Nordisk A/S | Peptide derivatives |
US7235627B2 (en) | 1996-08-30 | 2007-06-26 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
US6458924B2 (en) | 1996-08-30 | 2002-10-01 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
US6268343B1 (en) | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
BR9813111A (pt) * | 1997-10-24 | 2000-08-15 | Lilly Co Eli | Composições de insulina insolúveis |
US6531448B1 (en) | 1997-12-23 | 2003-03-11 | Eli Lilly And Company | Insoluble compositions for controlling blood glucose |
CA2342967A1 (en) * | 1998-12-08 | 2000-06-15 | Biovation Limited | Modifying protein immunogenicity |
TWI242000B (en) * | 1998-12-10 | 2005-10-21 | Univ Southern California | Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
WO2003094956A1 (en) | 2002-05-07 | 2003-11-20 | Novo Nordisk A/S | Soluble formulations comprising monomeric insulin and acylated insulin |
CN1247616C (zh) * | 2002-07-19 | 2006-03-29 | 上海中科生龙达生物技术(集团)有限公司 | 新的单体胰岛素,药物组合物及其制法 |
KR101159559B1 (ko) | 2003-08-05 | 2012-06-26 | 노보 노르디스크 에이/에스 | 신규의 인슐린 유도체 |
WO2005047508A1 (en) * | 2003-11-14 | 2005-05-26 | Novo Nordisk A/S | Processes for making acylated insulin |
ES2642214T3 (es) | 2004-01-21 | 2017-11-15 | Novo Nordisk Health Care Ag | Conjugación de péptidos mediante transglutaminasa |
WO2005089789A2 (en) | 2004-03-17 | 2005-09-29 | 7Tm Pharma A/S | Y2 selective receptor agonists for therapeutic interventions |
DK2060266T3 (da) | 2004-03-17 | 2011-11-14 | 7Tm Pharma As | Y4-selektiv receptoragonist PP2-36 til terapeutiske indgreb |
EP1846446B1 (en) | 2005-02-02 | 2013-06-26 | Novo Nordisk A/S | Insulin derivatives |
ES2490243T3 (es) | 2005-02-02 | 2014-09-03 | Novo Nordisk A/S | Derivados de insulina |
EP1969004B1 (en) | 2005-12-28 | 2011-08-10 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
WO2007096431A1 (en) * | 2006-02-27 | 2007-08-30 | Novo Nordisk A/S | Insulin derivatives |
MX2008014061A (es) * | 2006-05-09 | 2008-11-14 | Novo Nordisk As | Derivado de insulina. |
JP5550338B2 (ja) | 2006-07-31 | 2014-07-16 | ノボ・ノルデイスク・エー/エス | ペグ化持続型インスリン |
US9018161B2 (en) | 2006-09-22 | 2015-04-28 | Novo Nordisk A/S | Protease resistant insulin analogues |
JP5496082B2 (ja) | 2007-04-30 | 2014-05-21 | ノボ・ノルデイスク・エー/エス | タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物 |
JP5552046B2 (ja) | 2007-06-13 | 2014-07-16 | ノボ・ノルデイスク・エー/エス | インスリン誘導体を含有する薬学的製剤 |
EP2058330A1 (en) * | 2007-11-08 | 2009-05-13 | Novo Nordisk A/S | Insulin derivative |
JP5715418B2 (ja) | 2007-11-08 | 2015-05-07 | ノボ・ノルデイスク・エー/エス | インスリン誘導体 |
WO2009112583A2 (en) * | 2008-03-14 | 2009-09-17 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
PL2254906T3 (pl) | 2008-03-18 | 2017-04-28 | Novo Nordisk A/S | Stabilizowane względem proteaz, acylowane analogi insuliny |
RU2540922C2 (ru) | 2008-10-30 | 2015-02-10 | Ново Нордиск А/С | Лечение сахарного диабета с использованием инъекций инсулина с частотой менее одного раза в день |
BR112013010345A2 (pt) | 2010-10-27 | 2017-07-25 | Novo Nordisk As | tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção |
MX2014012096A (es) | 2012-04-11 | 2014-11-21 | Novo Nordisk As | Formulaciones de insulina. |
EP2991672A1 (en) | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Novel administration regime |
SI3055325T1 (en) | 2013-10-07 | 2018-05-31 | Novo Nordisk A/S | NEW DERIVATIVE ANALOGUE INSULINE |
AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
TWI700091B (zh) | 2016-12-16 | 2020-08-01 | 丹麥商諾佛 儂迪克股份有限公司 | 含胰島素醫藥組成物 |
TWI762706B (zh) | 2017-08-24 | 2022-05-01 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1組成物及其用途 |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
WO2020120479A1 (en) | 2018-12-11 | 2020-06-18 | Sanofi | Peptide binder |
BR112022013795A2 (pt) | 2020-02-18 | 2022-09-13 | Novo Nordisk As | Composição farmacêutica líquida, e, kit |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3844211A1 (de) * | 1988-12-29 | 1990-07-05 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
DK155690D0 (da) * | 1990-06-28 | 1990-06-28 | Novo Nordisk As | Nye peptider |
RO112873B1 (ro) * | 1993-09-17 | 1998-01-30 | Novo Nordisk As | Derivati de insulina |
-
1996
- 1996-03-18 HU HU9800523A patent/HUP9800523A3/hu unknown
- 1996-03-18 BR BR9607647A patent/BR9607647A/pt not_active Application Discontinuation
- 1996-03-18 DE DE69629210T patent/DE69629210T2/de not_active Expired - Lifetime
- 1996-03-18 PL PL96322299A patent/PL183698B1/pl unknown
- 1996-03-18 CA CA002215694A patent/CA2215694A1/en not_active Abandoned
- 1996-03-18 CN CN96193362A patent/CN1196061A/zh active Pending
- 1996-03-18 EP EP96905764A patent/EP0871665B1/en not_active Expired - Lifetime
- 1996-03-18 AT AT96905764T patent/ATE245659T1/de not_active IP Right Cessation
- 1996-03-18 JP JP52799596A patent/JP3872105B2/ja not_active Expired - Fee Related
- 1996-03-18 WO PCT/DK1996/000107 patent/WO1996029344A1/en not_active Application Discontinuation
- 1996-03-18 CZ CZ19972899A patent/CZ289343B6/cs not_active IP Right Cessation
- 1996-03-18 KR KR1019970706447A patent/KR19980703039A/ko not_active Application Discontinuation
- 1996-03-18 AU AU49396/96A patent/AU720966B2/en not_active Ceased
-
1997
- 1997-09-16 NO NO974270A patent/NO974270L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL322299A1 (en) | 1998-01-19 |
WO1996029344A1 (en) | 1996-09-26 |
JP3872105B2 (ja) | 2007-01-24 |
CZ289997A3 (cs) | 1998-01-14 |
AU4939696A (en) | 1996-10-08 |
DE69629210D1 (de) | 2003-08-28 |
PL183698B1 (pl) | 2002-06-28 |
EP0871665B1 (en) | 2003-07-23 |
ATE245659T1 (de) | 2003-08-15 |
HUP9800523A2 (hu) | 1998-06-29 |
CN1196061A (zh) | 1998-10-14 |
MX9707056A (es) | 1997-11-29 |
KR19980703039A (ko) | 1998-09-05 |
HUP9800523A3 (en) | 1998-09-28 |
NO974270L (no) | 1997-11-14 |
EP0871665A1 (en) | 1998-10-21 |
CZ289343B6 (cs) | 2002-01-16 |
JPH11502110A (ja) | 1999-02-23 |
AU720966B2 (en) | 2000-06-22 |
DE69629210T2 (de) | 2004-04-22 |
CA2215694A1 (en) | 1996-09-26 |
NO974270D0 (no) | 1997-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9607647A (pt) | Derivado de insulina e composição farmacêutica e processo para o tratamento de diabetes em um paciente em necessidade deste tratamento | |
HUP9904023A2 (hu) | Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban | |
BR9407508A (pt) | Derivado de insulina composição farmaceutica e processo para o tratamento de diabete em um paciente com necessidade deste tratamento | |
DE3881405T2 (de) | Antientzuendungsmittel. | |
EA200000652A1 (ru) | Кристаллы глюкагоноподобного пептида 1 | |
HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
BR0207700A (pt) | Método para tratar a diabete melito em um paciente em necessidade de tal tratamento, e, usos de um derivado de polipeptìdeo de insulina, e de um conjugado de polipeptìdeo de insulina-oligÈmero | |
PT1146896E (pt) | Formulacoes monodispersas de analogo acilado e hexamerico insulina | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
BR9810378A (pt) | Composto,uso do mesmo, composição farmacêutica, e, processos de tratar a diabete do tipo i ou do tipo ii, de tratar a hiperglicemia, e de diminuir a glicose do sangue em um mamìfero | |
AU1694392A (en) | Determination of motifs of peptides on mhc molecules | |
KR900002801A (ko) | 당뇨병 치료용 약학적제제 | |
KR950701818A (ko) | 탈-tyr 다이놀핀 동족체(des-tyr dynorphin analogues) | |
BR9811755A (pt) | Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica | |
KR900003205A (ko) | 제약 화합물 | |
AU601280B2 (en) | Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus | |
NO952336L (no) | Insulin analoger | |
NO955067L (no) | FVII/TF peptider | |
KR960000921A (ko) | 칼시토닌 유도체 및 그 용도 | |
AU2003292326A1 (en) | Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser | |
BR9810292A (pt) | Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase | |
ES2181923T3 (es) | 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina. | |
WO2007145208A1 (ja) | ペプチド誘導体 | |
KR950704358A (ko) | 카텝신 l 특이적 저해 폴리펩티드 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |